← Back to Search

Imaging Techniques for Hip Surgery Assessment

N/A

Recruiting

Led By David MacLeod

Research Sponsored by Duke University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Primary hip replacement

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up visit 1, up to 1 hour

Awards & highlights

Study Summary

This trial will compare muscle area & IMAT content of thigh muscles measured by CT & MSK ultrasound in hip replacement patients. It will compare two methods of measuring muscle area & IMAT content to assess muscle quality.

Who is the study for?

This trial is for patients scheduled for primary hip replacement surgery. It aims to compare muscle quality assessments using two different imaging techniques: CT scans and handheld ultrasound.Check my eligibility

What is being tested?

The study is testing the effectiveness of musculoskeletal (MSK) ultrasound against standard CT imaging in measuring muscle area and fat within muscles (IMAT) in the thigh, specifically in patients undergoing hip arthroplasty.See study design

What are the potential side effects?

CT scans involve exposure to X-rays, which carry a risk of radiation. Ultrasound does not use ionizing radiation and is considered safe with no known side effects related to this procedure.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ visit 1, up to 1 hour

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~visit 1, up to 1 hour

This trial's timeline: 3 weeks for screening, Varies for treatment, and visit 1, up to 1 hour for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

%IMAT

All IMAT

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: UltrasoundExperimental Treatment1 Intervention

Patients have ultrasound scans together with standard of care CT prior to primary hip replacement

Group II: CTActive Control1 Intervention

Patients have standard of care CT prior to primary hip replacement

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Ultrasound

2013

Completed Phase 1

~1950

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor

2,358 Previous Clinical Trials

3,420,029 Total Patients Enrolled

David MacLeodPrincipal InvestigatorDuke University

Media Library

CT Clinical Trial Eligibility Overview. Trial Name: NCT04126161 — N/A

Metabolic Muscle Profiling Research Study Groups: CT, Ultrasound

Metabolic Muscle Profiling Clinical Trial 2023: CT Highlights & Side Effects. Trial Name: NCT04126161 — N/A

CT 2023 Treatment Timeline for Medical Study. Trial Name: NCT04126161 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies for individuals interested in this exploratory research?

"Correct. The details of the trial, which were initially posted on November 1st 2019 and updated a month ago, are available on clinicaltrials.gov. This experiment seeks to recruit 40 participants from one centre."

Answered by AI

How many participants are actively engaged in this clinical experiment?

"Correct. According to clinicaltrials.gov, this medical experiment, which was initially shared on November 1st 2019 is actively recruiting patients for participation. 40 people are projected to be recruited from one site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

HIP: Hip Imaging Protocol

2019. "HIP: Hip Imaging Protocol". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04126161.